 By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Arrowhead Pharmaceuticals Inc NASDAQ:ARWR is developing medicines that cause gene silencing using RNA interference RNAi, a specific means of inhibiting the expression of genes and stopping the production of a specific protein. The company has a deep and diverse pipeline consisting of the following development 